# Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)

> **NCT00325221** · NA · COMPLETED · sponsor: **Biotronik SE & Co. KG** · enrollment: 148 (actual)

## Conditions studied

- Arrhythmia
- Quality of Life

## Interventions

- **DEVICE:** HM on
- **DEVICE:** HM Off

## Key facts

- **NCT ID:** NCT00325221
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-10
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325221, "Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00325221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*